From “Momentum” magazine: Dona Potter rode Harleys and drove 18-wheelers back when men dominated the open highways, and she is still defying expectations.
The 87-year-old from Tullahoma, Tennessee, has proven that age is not a barrier to tolerating and benefiting from chimeric antigen receptor cell therapy (CAR-T), a new immunotherapy that entails re-engineering a patient’s T cells to target cancer.